Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

76
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
76
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

431
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
431
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

760
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
760
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

334
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

74
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
74
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

504
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
504

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Awake tracheal intubation: A survey of practices, barriers and skills maintenance.

Anaesthesia and intensive care·2025
Same author

Consensus recommendations for paediatric airway topicalisation using lidocaine.

Anaesthesia·2025
Same author

A case series of incidents reported to webAIRS relating to glucagon-like peptide 1 agonist use.

Anaesthesia and intensive care·2025
Same author

Exploring Safety-II principles in anaesthetic airway management - a qualitative analysis of difficult and failed intubations reported to webAIRS.

Anaesthesia and intensive care·2025
Same author

Environmental Enrichment Attenuates Reproductive Adversity in a Mouse Model of Parkinson Disease.

Journal of the American Association for Laboratory Animal Science : JAALAS·2025
Same author

Difficult Health Conversations: Dilemmas That Vaccinated People in the United States Experienced When Discussing COVID-19 Vaccination with Hesitant Family Members.

Health communication·2025

Related Experiment Video

Updated: Nov 9, 2025

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

20.2K

LMA® Gastro™: A paediatric experience.

Charlotte L Taylor1,2, Steven R Wilson1,2, Laura L Burgoyne1

  • 1Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, Australia.

Anaesthesia and Intensive Care
|April 15, 2021
PubMed
Summary

The LMA® Gastro™ device provides a safe and effective airway for pediatric patients undergoing upper gastrointestinal endoscopy. This novel airway device demonstrated high success rates for both airway maintenance and endoscopic procedures in children.

Keywords:
Endoscopyairway managementgastroenterologypaediatricsupraglottic airway device

More Related Videos

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

392
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
10:34

Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy

Published on: November 20, 2021

5.7K

Related Experiment Videos

Last Updated: Nov 9, 2025

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

20.2K
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

392
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
10:34

Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy

Published on: November 20, 2021

5.7K

Area of Science:

  • Anesthesiology
  • Pediatric Gastroenterology

Background:

  • The LMA® Gastro™ is a novel airway device designed for upper gastrointestinal endoscopy.
  • Previous validation studies focused on adult populations, leaving a gap in pediatric data.

Purpose of the Study:

  • To evaluate the safety and efficacy of the LMA® Gastro™ in a pediatric population for elective upper GI endoscopy.
  • To assess airway and endoscopy outcomes associated with the LMA® Gastro™ in children.

Main Methods:

  • Prospective data collection over four months using a pre-existing endoscopy audit framework.
  • Inclusion of 55 pediatric patients undergoing elective upper GI endoscopy with the LMA® Gastro™ as the primary airway device.
  • Data captured by the treating anesthesiologist included airway and endoscopy outcomes.

Main Results:

  • The LMA® Gastro™ provided an adequate airway in 94.5% of patients (52/55).
  • Successful insertion on the first attempt was achieved in 88.5% of cases, with 96.2% rated as 'easy' by anesthesiologists.
  • Endoscopy success rate was 100% in patients with a successfully inserted airway, with 98% first-pass esophageal access.

Conclusions:

  • The LMA® Gastro™ is a highly successful airway device for pediatric patients undergoing elective upper GI endoscopy.
  • The device offers a valuable option for airway management and facilitates successful endoscopic procedures in children.
  • Despite initial inexperience, the LMA® Gastro™ demonstrated high efficacy and safety in this pediatric cohort.